Level Four Advisory Services LLC lowered its stake in CVS Health Corporation (NYSE:CVS) by 4.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,222 shares of the pharmacy operator’s stock after selling 954 shares during the period. Level Four Advisory Services LLC’s holdings in CVS Health Corporation were worth $1,488,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the company. Mercer Capital Advisers Inc. bought a new stake in CVS Health Corporation during the first quarter valued at $118,000. Orrstown Financial Services Inc. increased its stake in CVS Health Corporation by 2,000.0% in the first quarter. Orrstown Financial Services Inc. now owns 2,100 shares of the pharmacy operator’s stock valued at $165,000 after buying an additional 2,000 shares during the last quarter. SRS Capital Advisors Inc. increased its stake in CVS Health Corporation by 48.2% in the first quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock valued at $177,000 after buying an additional 734 shares during the last quarter. Edmp Inc. bought a new stake in CVS Health Corporation during the first quarter valued at $202,000. Finally, Pinnacle Bank bought a new stake in CVS Health Corporation during the first quarter valued at $203,000. Institutional investors and hedge funds own 81.92% of the company’s stock.

CVS Health Corporation (CVS) traded up 0.34% during mid-day trading on Friday, reaching $79.41. 1,151,146 shares of the company’s stock were exchanged. CVS Health Corporation has a 52 week low of $69.30 and a 52 week high of $98.44. The stock has a 50-day moving average price of $78.77 and a 200-day moving average price of $78.97. The stock has a market cap of $80.73 billion, a P/E ratio of 15.82 and a beta of 0.91.

CVS Health Corporation (NYSE:CVS) last issued its earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The firm had revenue of $45.69 billion for the quarter, compared to analysts’ expectations of $45.36 billion. During the same quarter last year, the business earned $1.32 earnings per share. The company’s revenue was up 4.5% compared to the same quarter last year. On average, analysts forecast that CVS Health Corporation will post $5.88 earnings per share for the current year.

The business also recently announced a quarterly dividend, which was paid on Thursday, August 3rd. Shareholders of record on Monday, July 24th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.53%. The ex-dividend date was Thursday, July 20th. CVS Health Corporation’s dividend payout ratio (DPR) is currently 39.92%.

TRADEMARK VIOLATION NOTICE: This news story was published by Watch List News and is the property of of Watch List News. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.watchlistnews.com/level-four-advisory-services-llc-sells-954-shares-of-cvs-health-corporation-cvs/1475531.html.

Several equities research analysts recently weighed in on the stock. Vetr downgraded shares of CVS Health Corporation from a “strong-buy” rating to a “buy” rating and set a $88.97 price objective for the company. in a report on Monday, June 12th. Guggenheim reaffirmed a “buy” rating on shares of CVS Health Corporation in a report on Monday, July 3rd. Needham & Company LLC assumed coverage on shares of CVS Health Corporation in a report on Tuesday, June 27th. They issued a “hold” rating for the company. Jefferies Group LLC reaffirmed a “hold” rating and issued a $82.00 price objective on shares of CVS Health Corporation in a report on Friday, July 14th. Finally, BidaskClub downgraded shares of CVS Health Corporation from a “hold” rating to a “sell” rating in a report on Monday, July 24th. Eight equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. CVS Health Corporation presently has a consensus rating of “Buy” and an average price target of $91.27.

In other CVS Health Corporation news, EVP Helena Foulkes sold 20,332 shares of the firm’s stock in a transaction dated Monday, June 19th. The stock was sold at an average price of $76.98, for a total transaction of $1,565,157.36. Following the transaction, the executive vice president now owns 59,300 shares in the company, valued at $4,564,914. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CFO David M. Denton sold 230,510 shares of the firm’s stock in a transaction dated Monday, June 12th. The stock was sold at an average price of $80.00, for a total value of $18,440,800.00. Following the transaction, the chief financial officer now owns 176,983 shares in the company, valued at approximately $14,158,640. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 271,175 shares of company stock worth $21,632,597. Company insiders own 0.61% of the company’s stock.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.